PAVmed Inc PAVM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways
-
PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results
-
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results
-
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
-
Lucid Diagnostics to Participate in Upcoming Investor Conferences
-
PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026
-
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026
Trading Information
- Previous Close Price
- $2.69
- Day Range
- $2.58–2.89
- 52-Week Range
- $2.58–28.44
- Bid/Ask
- $2.50 / $2.95
- Shares Outstanding
- 8.00M
- Market Cap
- $22.31M
- Volume/Avg
- 12,150 / 29,799
Key Statistics
- Price/Earnings (Normalized)
- 0.12
- Price/Sales
- 59.11
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- < 0.01%
Company Profile
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 41
- Website
- https://www.pavmed.com
Valuation
|
Metric
|
PAVM
|
|---|---|
Price/Earnings (Normalized) | 0.12 |
Price/Book Value | 0.65 |
Price/Sales | 59.11 |
Price/Cash Flow | — |
Price/Earnings
PAVM
Financial Strength
|
Metric
|
PAVM
|
|---|---|
Quick Ratio | 0.93 |
Current Ratio | 1.19 |
Interest Coverage | −914.22 |
Quick Ratio
PAVM
Profitability
|
Metric
|
PAVM
|
|---|---|
Return on Assets (Normalized) | −27.36% |
Return on Equity (Normalized) | −57.82% |
Return on Invested Capital (Normalized) | −29.82% |
Return on Assets
PAVM
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|h#%t^t | LOCK|S?$&b | $172B | |||
| Medtronic PLC
MDT
| LOCK|!#^Wn< | LOCK|h$J$$ | $113B | |||
| Stryker Corp
SYK
| LOCK|n^L$fD> | LOCK|f&s | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|>kWXk@ | LOCK|hn@s | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|$!D>@!@p | LOCK|KmK@> | $49B | |||
| DexCom Inc
DXCM
| LOCK|#r&%&^H! | LOCK|qHnh | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|<vC@zk? | LOCK|K%# | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Q! | LOCK|$^< | $24B | |||
| Steris PLC
STE
| LOCK|pwKqZ>g | LOCK|b!>^r | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|?BCGC!#y | LOCK|Dt | $17B |
United States